Helvepharm AG - Candesartan HCT Zentiva 16/12.5mg, Tabletten |
| 62321 | | 02 | | Candesartan HCT Zentiva 16/12.5mg | | Tabletten | | C09DA06 | | Candesartan und Diuretika | | 30.01.2012 | | |
|
Composition |
candesartanum cilexetilum 16 mg, hydrochlorothiazidum 12.5 mg, maydis amylum, lactosum monohydricum 109.3 mg, triethylis citras, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.36 mg, magnesii stearas, pro compresso. |
Packungsbestandteile |
| Comprimés | | | Principe actif | Concentr. |
---|
Candesartanum Cilexetil | 16 mg | Hydrochlorothiazide | 12.5 mg |
| BAG: Principe actif | Concentr. |
---|
Candesartanum Cilexetil | 16 mg | Hydrochlorothiazide | 12.5 mg |
| | Agents auxilliaires | Concentr. |
---|
Carmellosum Natricum Conexum | | Hydroxypropylcellulosum | | Lactose Monohydrate | 109.3 mg | Magnesii Stearas | | Maydis Amylum | | Pro Compresso | | Triethylis Citras | |
| |
|
|